Follow
banu iskender
banu iskender
Kocaeli University Faculty of Medicine Department of Medical Biology
Verified email at kocaeli.edu.tr - Homepage
Title
Cited by
Cited by
Year
The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer
Ç Şakalar, K İzgi, B İskender, S Sezen, H Aksu, M Çakır, B Kurt, A Turan, ...
Tumor Biology 37 (4), 4467-4477, 2016
822016
Integrin-associated focal adhesion kinase protects human embryonic stem cells from apoptosis, detachment, and differentiation
L Vitillo, M Baxter, B Iskender, P Whiting, SJ Kimber
Stem cell reports 7 (2), 167-176, 2016
672016
Comparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenance
D Soteriou, B Iskender, A Byron, JD Humphries, S Borg-Bartolo, ...
Journal of Biological Chemistry 288 (26), 18716-18731, 2013
572013
Novel anti-cancer agent myrtucommulone-A and thymoquinone abrogate epithelial–mesenchymal transition in cancer cells mainly through the inhibition of PI3K/AKT signalling axis
B Iskender, K Izgi, H Canatan
Molecular and cellular biochemistry 416 (1), 71-84, 2016
432016
Inhibition of epithelial-mesenchymal transition in bladder cancer cells via modulation of mTOR signalling
B Iskender, K Izgi, E Hizar, J Jauch, A Arslanhan, EH Yuksek, H Canatan
Tumor Biology 37 (6), 8281-8291, 2016
412016
Myrtucommulone‐A Induces both Extrinsic and Intrinsic Apoptotic Pathways in Cancer Cells
K Izgi, B Iskender, J Jauch, S Sezen, M Cakir, M Charpentier, H Canatan, ...
Journal of biochemical and molecular toxicology 29 (9), 432-439, 2015
322015
Reprogramming bladder cancer cells for studying cancer initiation and progression
B Iskender, K Izgi, H Canatan
Tumor Biology 37 (10), 13237-13245, 2016
252016
Current status in cancer cell reprogramming and its clinical implications
K Izgi, H Canatan, B Iskender
232017
Myrtucommulone-A treatment decreases pluripotency-and multipotency-associated marker expression in bladder cancer cell line HTB-9
B Iskender, K Izgi, H Karaca, H Canatan
Journal of natural medicines 69 (4), 543-554, 2015
192015
Human feeder cell line for derivation and culture of hESc/hiPSc
TR McKay, MV Camarasa, B Iskender, J Ye, N Bates, D Miller, ...
Stem Cell Research 7 (2), 154-162, 2011
192011
Priming hMSCs with a putative anti-cancer compound, myrtucommulone-a: a way to harness hMSC cytokine expression via modulating PI3K/Akt pathway?
B Iskender, K Izgi, C Sakalar, H Canatan
Tumor Biology 37 (2), 1967-1981, 2016
152016
Long term exposure to myrtucommulone-A changes CD105 expression and differentiation potential of mesenchymal stem cells
K Izgi, MF Sonmez, H Canatan, B Iskender
Tissue engineering and regenerative medicine 14 (2), 113-121, 2017
122017
Effects of epirubicin and cisplatin against 4T1 breast cancer cells are enhanced by myrtucommulone-A
K Izgi, B Iskender, C Sakalar, A Arslanhan, E Hilal Yuksek, E Hizar, ...
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2017
92017
Evaluation of two different adjuvants with immunogenic uroplakin 3A-derived peptide for their ability to evoke an immune response in mice
K Izgi, B Iskender, C Sakalar, A Arslanhan, B Saraymen, H Canatan
European Cytokine Network 26 (2), 46-56, 2015
92015
İndüklenmiş pluripotent kök hücreler ve hücre tedavisi
B İskender, H Canatan
Journal of Clinical and Experimental Investigations 4 (4), 550-561, 2013
9*2013
Induced pluripotent stem cells and cell therapy
B İskender, H Canatan
Journal of Clinical and Experimental Investigations; Cilt: 4 Sayı: 4, 2013
22013
İnsan embriyonik kök hücreleri ve mikroçevre
B İskender, K İzgi, S Şanlıoğlu, H Canatan
Journal of Clinical and Experimental Investigations 5 (3), 486-495, 2014
12014
The Active Compound Thymoquinone Alters Chondrogenic Differentiation of Human Mesenchymal Stem Cells via Modulation of Intracellular Signaling
B ISKENDER
Medeniyet Medical Journal 37 (1), 1, 2022
2022
Development of an autoimmune-mediated strategy for bladder cancer vaccination in mice
K Izgi, B Iskender, HB Ulusoy, H Canatan
2016
Comparative proteomic analysis of supportive amd unsupportive extracellular matrix substrates for human embryonic stem cell maintenance
SJ Kimber, D Soteriou, B Iskender, A Byron, JD Humphries, ...
Journal of Biological Chemistry, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–20